Insider Shareholders with Direct Ownership of Eagle Pharmaceuticals, Inc. (EGRX)
This section provides a comprehensive overview of the insiders with direct ownership of Eagle Pharmaceuticals, Inc. (EGRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
EAGLE PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 149,851 | 159,380 | 460,621 $276,372 | 21 |
Feb 28, 2024
Reduced 0.46%
|
|
|
David Pernock
Pres & Chief Operating Officer |
9,700 | 4,886 | 54,625 $32,775 | 4 |
Feb 02, 2021
Added 15.08%
|
|
Brian Joseph Cahill
CHIEF FINANCIAL OFFICER |
44,200 | 11,528 | 47,958 $28,774 | 22 |
Feb 27, 2024
Reduced 3.21%
|
|
Michael Shawn Moran
EVP, Chief Commercial Officer |
10,400 | 2,553 | 32,115 $19,269 | 5 |
Feb 28, 2022
Added 24.46%
|
|
Steven B Ratoff
Director |
9,360 | 0 | 27,364 $16,418 | 2 |
Apr 08, 2021
Added 7.88%
|
|
Richard A. Edlin
Director |
0 | 6,800 | 22,600 $13,560 | 1 |
Sep 06, 2022
Reduced 23.13%
|
|
Michael Graves
Interim Executive Chair & PEO |
9,360 | 0 | 10,360 $6,216 | 1 |
Oct 27, 2023
Added 47.46%
|
|
Judith Ng Cashin
Chief Medical Officer |
2,000 | 0 | 2,000 $1,200 | 1 |
Feb 02, 2021
Added 50.0%
|